Xencor

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.

About XNCR

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. 

CEO
Bassil I. Dahiyat
CEOBassil I. Dahiyat
Employees
280
Employees280
Headquarters
Pasadena, California
HeadquartersPasadena, California
Founded
1997
Founded1997
Employees
280
Employees280

XNCR Key Statistics

Market cap
1.86B
Market cap1.86B
Price-Earnings ratio
-8.39
Price-Earnings ratio-8.39
Dividend yield
Dividend yield
Average volume
687.92K
Average volume687.92K
High today
$26.93
High today$26.93
Low today
$26.46
Low today$26.46
Open price
$26.69
Open price$26.69
Volume
167.75K
Volume167.75K
52 Week high
$27.20
52 Week high$27.20
52 Week low
$15.31
52 Week low$15.31

XNCR News

Simply Wall St 6h
Xencor, Inc.'s 26% Share Price Surge Not Quite Adding Up

Despite an already strong run, Xencor, Inc. ( ) shares have been powering on, with a gain of 26% in the last thirty days. The last 30 days bring the annual gain...

Xencor, Inc.'s 26% Share Price Surge Not Quite Adding Up

Analyst ratings

91%

of 11 ratings
Buy
90.9%
Hold
0%
Sell
9.1%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.